{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T05:08:29Z","timestamp":1716440909967},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00392-020-01779-7","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T15:05:03Z","timestamp":1605884703000},"page":"1221-1233","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Intensification of pharmacological decongestion but not the actual daily loop diuretic dose predicts worse chronic heart failure outcome: insights from TIME-CHF"],"prefix":"10.1007","volume":"110","author":[{"given":"Justas","family":"Simonavi\u010dius","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha T.","family":"Maeder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casper G. M. J.","family":"Eurlings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arantxa Barandiar\u00e1n","family":"Aizpurua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelena","family":"\u010celutkien\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u016brat\u0117","family":"Barysien\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Toggweiler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beat A.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Peter","family":"Brunner-La Rocca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,20]]},"reference":[{"key":"1779_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10741-018-9735-7","volume":"24","author":"J Simonavi\u010dius","year":"2019","unstructured":"Simonavi\u010dius J, Knackstedt C, Brunner-La Rocca H-P (2019) Loop diuretics in chronic heart failure: how to manage congestion? Heart Fail Rev 24:17\u201330. https:\/\/doi.org\/10.1007\/s10741-018-9735-7","journal-title":"Heart Fail Rev"},{"key":"1779_CR2","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureThe Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129\u20132200. https:\/\/doi.org\/10.1093\/eurheartj\/ehw128","journal-title":"Eur Heart J"},{"key":"1779_CR3","doi-asserted-by":"publisher","first-page":"e679","DOI":"10.1016\/j.amjmed.2019.04.010","volume":"132","author":"J Simonavi\u010dius","year":"2019","unstructured":"Simonavi\u010dius J, Sanders van-Wijk S, Rickenbacher P et al (2019) Prognostic significance of longitudinal clinical congestion pattern in chronic heart failure: insights from TIME-CHF trial. Am J Med 132:e679\u2013e692. https:\/\/doi.org\/10.1016\/j.amjmed.2019.04.010","journal-title":"Am J Med"},{"key":"1779_CR4","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1161\/CIRCULATIONAHA.108.783910","volume":"118","author":"MR Zile","year":"2008","unstructured":"Zile MR, Bennett TD, St John Sutton M et al (2008) Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures. Circulation 118:1433\u20131441. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.783910","journal-title":"Circulation"},{"key":"1779_CR5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1161\/CIRCULATIONAHA.109.933275","volume":"122","author":"JM Testani","year":"2010","unstructured":"Testani JM, Chen J, McCauley BD et al (2010) Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 122:265\u2013272. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.933275","journal-title":"Circulation"},{"key":"1779_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-020-01642-9","author":"A Palazzuoli","year":"2020","unstructured":"Palazzuoli A, Ruocco G, Franci B et al (2020) Ultrasound indices of congestion in patients with acute heart failure according to body mass index. Clin Res Cardiol. https:\/\/doi.org\/10.1007\/s00392-020-01642-9","journal-title":"Clin Res Cardiol"},{"key":"1779_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-020-01639-4","author":"M Kobayashi","year":"2020","unstructured":"Kobayashi M, Girerd N, Duarte K et al (2020) Prognostic impact of plasma volume estimated from hemoglobin and hematocrit in heart failure with preserved ejection fraction. Clin Res Cardiol. https:\/\/doi.org\/10.1007\/s00392-020-01639-4","journal-title":"Clin Res Cardiol"},{"key":"1779_CR8","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00392-018-1385-1","volume":"108","author":"M Kobayashi","year":"2019","unstructured":"Kobayashi M, Rossignol P, Ferreira JP et al (2019) Prognostic value of estimated plasma volume in acute heart failure in three cohort studies. Clin Res Cardiol 108:549\u2013561. https:\/\/doi.org\/10.1007\/s00392-018-1385-1","journal-title":"Clin Res Cardiol"},{"key":"1779_CR9","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","volume":"377","author":"WT Abraham","year":"2011","unstructured":"Abraham WT, Adamson PB, Bourge RC et al (2011) Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 377:658\u2013666. https:\/\/doi.org\/10.1016\/S0140-6736(11)60101-3","journal-title":"Lancet"},{"key":"1779_CR10","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/ejhf.1697","volume":"22","author":"W Mullens","year":"2020","unstructured":"Mullens W, Damman K, Testani JM et al (2020) Evaluation of kidney function throughout the heart failure trajectory: a position statement from the heart failure association of the European society of cardiology. Eur J Heart Fail 22:584\u2013603. https:\/\/doi.org\/10.1002\/ejhf.1697","journal-title":"Eur J Heart Fail"},{"key":"1779_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jchf.2018.10.010","volume":"7","author":"H-P Brunner-La Rocca","year":"2019","unstructured":"Brunner-La Rocca H-P, Linssen GC, Smeele FJ et al (2019) Contemporary drug treatment of chronic heart failure with reduced ejection fraction: the CHECK-HF registry. JACC Heart Fail 7:13\u201321. https:\/\/doi.org\/10.1016\/j.jchf.2018.10.010","journal-title":"JACC Heart Fail"},{"key":"1779_CR12","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.amjcard.2005.12.072","volume":"97","author":"S Eshaghian","year":"2006","unstructured":"Eshaghian S, Horwich TB, Fonarow GC (2006) Relation of loop diuretic dose to mortality in advanced heart failure. Am J Cardiol 97:1759\u20131764. https:\/\/doi.org\/10.1016\/j.amjcard.2005.12.072","journal-title":"Am J Cardiol"},{"key":"1779_CR13","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/ejhf.462","volume":"18","author":"K Damman","year":"2016","unstructured":"Damman K, Kjekshus J, Wikstrand J et al (2016) Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction. Eur J Heart Fail 18:328\u2013336. https:\/\/doi.org\/10.1002\/ejhf.462","journal-title":"Eur J Heart Fail"},{"key":"1779_CR14","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ijcard.2018.04.090","volume":"267","author":"CA Lawson","year":"2018","unstructured":"Lawson CA, Testani JM, Mamas M et al (2018) Chronic kidney disease, worsening renal function and outcomes in a heart failure community setting: a UK national study. Int J Cardiol 267:120\u2013127. https:\/\/doi.org\/10.1016\/j.ijcard.2018.04.090","journal-title":"Int J Cardiol"},{"key":"1779_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/ejhf.1402","volume":"21","author":"O Vardeny","year":"2019","unstructured":"Vardeny O, Claggett B, Kachadourian J et al (2019) Reduced loop diuretic use in patients taking sacubitril\/valsartan compared with enalapril: the PARADIGM-HF trial. Eur J Heart Fail 21:337\u2013341. https:\/\/doi.org\/10.1002\/ejhf.1402","journal-title":"Eur J Heart Fail"},{"key":"1779_CR16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1001\/jama.2009.2","volume":"301","author":"M Pfisterer","year":"2009","unstructured":"Pfisterer M, Buser P, Rickli H et al (2009) BNP-guided vs symptom-guided heart failure therapy: the trial of intensified vs standard medical therapy in elderly patients with congestive heart failure (TIME-CHF) randomized trial. JAMA 301:383\u2013392. https:\/\/doi.org\/10.1001\/jama.2009.2","journal-title":"JAMA"},{"key":"1779_CR17","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.ahj.2005.10.022","volume":"151","author":"HP Brunner-La Rocca","year":"2006","unstructured":"Brunner-La Rocca HP, Buser PT, Schindler R et al (2006) Management of elderly patients with congestive heart failure\u2013design of the trial of intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF). Am Heart J 151:949\u2013955. https:\/\/doi.org\/10.1016\/j.ahj.2005.10.022","journal-title":"Am Heart J"},{"key":"1779_CR18","doi-asserted-by":"publisher","first-page":"e330","DOI":"10.1016\/j.amjmed.2019.12.011","volume":"133","author":"J Simonavicius","year":"2020","unstructured":"Simonavicius J, Puronaite R, Brunner-La Rocca H-P (2020) The reply. Am J Med 133:e330\u2013e332. https:\/\/doi.org\/10.1016\/j.amjmed.2019.12.011","journal-title":"Am J Med"},{"issue":"407\u2013414","key":"1779_CR19","doi-asserted-by":"publisher","first-page":"414.e1","DOI":"10.1016\/j.ahj.2011.12.003","volume":"163","author":"MT Maeder","year":"2012","unstructured":"Maeder MT, Rickli H, Pfisterer ME et al (2012) Incidence, clinical predictors, and prognostic impact of worsening renal function in elderly patients with chronic heart failure on intensive medical therapy. Am Heart J 163(407\u2013414):414.e1. https:\/\/doi.org\/10.1016\/j.ahj.2011.12.003","journal-title":"Am Heart J"},{"key":"1779_CR20","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1093\/eurheartj\/ehx035","volume":"38","author":"W Mullens","year":"2017","unstructured":"Mullens W, Verbrugge FH, Nijst P, Tang WHW (2017) Renal sodium avidity in heart failure: from pathophysiology to treatment strategies. Eur Heart J 38:1872\u20131882. https:\/\/doi.org\/10.1093\/eurheartj\/ehx035","journal-title":"Eur Heart J"},{"key":"1779_CR21","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1161\/CIRCHEARTFAILURE.114.001957","volume":"8","author":"L Anuradha","year":"2015","unstructured":"Anuradha L, McNulty SE, Mentz RJ et al (2015) Relief and recurrence of congestion during and after hospitalization for acute heart failure. Circ Heart Failure 8:741\u2013748. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.114.001957","journal-title":"Circ Heart Failure"},{"key":"1779_CR22","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1161\/CIRCULATIONAHA.119.039920","volume":"140","author":"S Selvaraj","year":"2019","unstructured":"Selvaraj S, Claggett B, Pozzi A et al (2019) prognostic implications of congestion on physical examination among contemporary patients with heart failure and reduced ejection fraction: PARADIGM-HF. Circulation 140:1369\u20131379. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.039920","journal-title":"Circulation"},{"key":"1779_CR23","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1161\/CIR.0b013e31829e8776","volume":"128","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B et al (2013) 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American college of cardiology foundation\/American heart association task force on practice guidelines. Circulation 128:e240\u2013e327. https:\/\/doi.org\/10.1161\/CIR.0b013e31829e8776","journal-title":"Circulation"},{"key":"1779_CR24","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1056\/NEJMra1703100","volume":"377","author":"DH Ellison","year":"2017","unstructured":"Ellison DH, Felker GM (2017) Diuretic treatment in heart failure. N Engl J Med 377:1964\u20131975. https:\/\/doi.org\/10.1056\/NEJMra1703100","journal-title":"N Engl J Med"},{"key":"1779_CR25","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1005419","volume":"364","author":"GM Felker","year":"2011","unstructured":"Felker GM, Lee KL, Bull DA et al (2011) Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364:797\u2013805. https:\/\/doi.org\/10.1056\/NEJMoa1005419","journal-title":"N Engl J Med"},{"key":"1779_CR26","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1093\/eurheartj\/ehz554","volume":"40","author":"LE Rohde","year":"2019","unstructured":"Rohde LE, Rover MM, Figueiredo Neto JA et al (2019) Short-term diuretic withdrawal in stable outpatients with mild heart failure and no fluid retention receiving optimal therapy: a double-blind, multicentre, randomized trial. Eur Heart J 40:3605\u20133612. https:\/\/doi.org\/10.1093\/eurheartj\/ehz554","journal-title":"Eur Heart J"},{"key":"1779_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1839","author":"J Simonavicius","year":"2020","unstructured":"Simonavicius J, Brunner-La Rocca H-P (2020) Do chronic heart failure patients receive optimal decongestive interventions in a real-life setting? Eur J Heart Fail. https:\/\/doi.org\/10.1002\/ejhf.1839","journal-title":"Eur J Heart Fail"},{"key":"1779_CR28","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/eurheartj\/ehi890","volume":"27","author":"A Ahmed","year":"2006","unstructured":"Ahmed A, Husain A, Love TE et al (2006) Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J 27:1431\u20131439. https:\/\/doi.org\/10.1093\/eurheartj\/ehi890","journal-title":"Eur Heart J"},{"key":"1779_CR29","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1253\/circj.CJ-11-1196","volume":"76","author":"S Hamaguchi","year":"2012","unstructured":"Hamaguchi S, Kinugawa S, Tsuchihashi-Makaya M et al (2012) Loop diuretic use at discharge is associated with adverse outcomes in hospitalized patients with heart failure: a report from the Japanese cardiac registry of heart failure in cardiology (JCARE-CARD). Circ J 76:1920\u20131927","journal-title":"Circ J"},{"key":"1779_CR30","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1007\/s00392-020-01598-w","volume":"109","author":"TM Jm","year":"2020","unstructured":"Jm TM, M P, D K et al (2020) Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction. Clin Res Cardiol 109:1048\u20131059. https:\/\/doi.org\/10.1007\/s00392-020-01598-w","journal-title":"Clin Res Cardiol"},{"key":"1779_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1067\/mhj.2002.123144","volume":"144","author":"GW Neuberg","year":"2002","unstructured":"Neuberg GW, Miller AB, O\u2019Connor CM et al (2002) Diuretic resistance predicts mortality in patients with advanced heart failure. Am Heart J 144:31\u201338","journal-title":"Am Heart J"},{"key":"1779_CR32","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ahj.2010.05.032","volume":"160","author":"HM Abdel-Qadir","year":"2010","unstructured":"Abdel-Qadir HM, Tu JV, Yun L et al (2010) Diuretic dose and long-term outcomes in elderly patients with heart failure after hospitalization. Am Heart J 160:264-271.e1. https:\/\/doi.org\/10.1016\/j.ahj.2010.05.032","journal-title":"Am Heart J"},{"key":"1779_CR33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1751-7133.2011.00252.x","volume":"18","author":"FL Dini","year":"2012","unstructured":"Dini FL, Guglin M, Simioniuc A et al (2012) Association of furosemide dose with clinical status, left ventricular dysfunction, natriuretic peptides, and outcome in clinically stable patients with chronic systolic heart failure. Congest Heart Fail 18:98\u2013106. https:\/\/doi.org\/10.1111\/j.1751-7133.2011.00252.x","journal-title":"Congest Heart Fail"},{"key":"1779_CR34","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s11739-018-02019-7","volume":"14","author":"J-C Trull\u00e0s","year":"2019","unstructured":"Trull\u00e0s J-C, Casado J, Morales-Rull J-L et al (2019) Prevalence and outcome of diuretic resistance in heart failure. Intern Emerg Med 14:529\u2013537. https:\/\/doi.org\/10.1007\/s11739-018-02019-7","journal-title":"Intern Emerg Med"},{"key":"1779_CR35","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.repc.2018.03.014","volume":"37","author":"SI Jardim","year":"2018","unstructured":"Jardim SI, Ramos Dos Santos L, Ara\u00fajo I et al (2018) A 2018 overview of diuretic resistance in heart failure. Rev Port Cardiol 37:935\u2013945. https:\/\/doi.org\/10.1016\/j.repc.2018.03.014","journal-title":"Rev Port Cardiol"},{"key":"1779_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-020-01617-w","author":"A Galluzzo","year":"2020","unstructured":"Galluzzo A, Frea S, Boretto P et al (2020) Spot urinary sodium in acute decompensation of advanced heart failure and dilutional hyponatremia: insights from DRAIN trial. Clin Res Cardiol. https:\/\/doi.org\/10.1007\/s00392-020-01617-w","journal-title":"Clin Res Cardiol"},{"key":"1779_CR37","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/1753944717718717","volume":"11","author":"N Shah","year":"2017","unstructured":"Shah N, Madanieh R, Alkan M et al (2017) A perspective on diuretic resistance in chronic congestive heart failure. Ther Adv Cardiovasc Dis 11:271\u2013278. https:\/\/doi.org\/10.1177\/1753944717718717","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"1779_CR38","doi-asserted-by":"publisher","first-page":"F374","DOI":"10.1152\/ajprenal.1985.248.3.F374","volume":"248","author":"B Kaissling","year":"1985","unstructured":"Kaissling B, Bachmann S, Kriz W (1985) Structural adaptation of the distal convoluted tubule to prolonged furosemide treatment. Am J Physiol 248:F374-381. https:\/\/doi.org\/10.1152\/ajprenal.1985.248.3.F374","journal-title":"Am J Physiol"},{"key":"1779_CR39","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1681\/ASN.2016111178","volume":"28","author":"VS Rao","year":"2017","unstructured":"Rao VS, Planavsky N, Hanberg JS et al (2017) Compensatory distal reabsorption drives diuretic resistance in human heart failure. J Am Soc Nephrol 28:3414\u20133424. https:\/\/doi.org\/10.1681\/ASN.2016111178","journal-title":"J Am Soc Nephrol"},{"key":"1779_CR40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/ejhf.210","volume":"17","author":"H-P Brunner-La Rocca","year":"2015","unstructured":"Brunner-La Rocca H-P, Knackstedt C, Eurlings L et al (2015) Impact of worsening renal function related to medication in heart failure. Eur J Heart Fail 17:159\u2013168. https:\/\/doi.org\/10.1002\/ejhf.210","journal-title":"Eur J Heart Fail"},{"key":"1779_CR41","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1161\/01.CIR.102.2.203","volume":"102","author":"L Hillege Hans","year":"2000","unstructured":"Hillege Hans L, Girbes Armand RJ, de Kam Pieter et al (2000) Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102:203\u2013210. https:\/\/doi.org\/10.1161\/01.CIR.102.2.203","journal-title":"Circulation"},{"key":"1779_CR42","doi-asserted-by":"publisher","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","volume":"139","author":"J Rangaswami","year":"2019","unstructured":"Rangaswami J, Bhalla V, Blair JEA et al (2019) Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation 139:e840\u2013e878. https:\/\/doi.org\/10.1161\/CIR.0000000000000664","journal-title":"Circulation"},{"key":"1779_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/ehf2.12364","volume":"6","author":"J Boulos","year":"2019","unstructured":"Boulos J, Darawsha W, Abassi ZA et al (2019) Treatment patterns of patients with acute heart failure who develop acute kidney injury. ESC Heart Fail 6:45\u201352. https:\/\/doi.org\/10.1002\/ehf2.12364","journal-title":"ESC Heart Fail"},{"key":"1779_CR44","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1161\/CIRCHEARTFAILURE.111.963413","volume":"5","author":"M Metra","year":"2012","unstructured":"Metra M, Davison B, Bettari L et al (2012) Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail 5:54\u201362. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.111.963413","journal-title":"Circ Heart Fail"},{"key":"1779_CR45","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/eurheartj\/ehv010","volume":"36","author":"K Damman","year":"2015","unstructured":"Damman K, Testani JM (2015) The kidney in heart failure: an update. Eur Heart J 36:1437\u20131444. https:\/\/doi.org\/10.1093\/eurheartj\/ehv010","journal-title":"Eur Heart J"},{"key":"1779_CR46","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1001\/jama.1989.03420060100040","volume":"261","author":"LW Stevenson","year":"1989","unstructured":"Stevenson LW, Perloff JK (1989) The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 261:884\u2013888","journal-title":"JAMA"},{"key":"1779_CR47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911303","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE et al (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. New Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa1911303 (0:null)","journal-title":"New Engl J Med"},{"key":"1779_CR48","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2022190","author":"M Packer","year":"2020","unstructured":"Packer M, Anker SD, Butler J et al (2020) Cardiovascular and renal outcomes with empagliflozin in heart failure. New Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2022190 (0:null)","journal-title":"New Engl J Med"},{"key":"1779_CR49","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.048739","author":"NA Mordi","year":"2020","unstructured":"Mordi NA, Mordi IR, Singh JS et al (2020) Renal and cardiovascular effects of SGLT2 inhibition in combination with loop diuretics in patients with Type 2 diabetes and chronic heart failure: the RECEDE-CHF trial. Circulation. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.048739","journal-title":"Circulation"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-020-01779-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-020-01779-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-020-01779-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T12:06:37Z","timestamp":1627473997000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-020-01779-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,20]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1779"],"URL":"https:\/\/doi.org\/10.1007\/s00392-020-01779-7","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,20]]},"assertion":[{"value":"19 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest\/competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The investigation was approved by the local ethics committees.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All the participants provided their written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The consent for publication was a part of the written informed consent provided by each participant.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}